About Us

Celebrating Over 20 Years Of Innovation, Commitment, and Expertise

Cmed Is Where Technology Meets Expertise.

No other CRO is better prepared to support biotech and biopharma sponsors deliver the future of clinical trials.

Technology-led and with specialty expertise in oncology, cell & gene therapy, rare diseases, data science and analytics, we pioneered the processes for delivering next generation trials.

As the global pharmaceutical industry continues to undergo seismic change, our 20 years of innovation, commitment and expertise enable us to embrace radical disruption and transform the clinical trials landscape for the benefit of patients.

We anticipate. We adapt. We embrace every challenge. We are where you want to be.

Get to know us:

Therapeutic ExpertiseFunctional Service Provision (FSP)CRO Solutions, and Technology

 

Guiding Principles

 

Our achievements

Helping our clients reach new milestones

100%

Staff have Oncology Experience

We are focused on serving the biopharma/biotech market and strive to be a consultative and proactive oncology CRO partner.

100%

Interim and Final Deliveries are Early or On-Time

Over the last 20 years, our 140-strong Data Science & Analytics team has delivered more than 700 studies across multiple Therapeutic areas and all phases: from complex early phase trials to global trials involving over 10,000 patients.

100%

of Cmed Project Leaders have Cell & Gene Therapy Experience

We manage complex Cell & Gene therapy clinical trials for multiple sponsors in oncology, rare diseases and other therapeutic areas.

Our Executive Team Members

  • Stephanie Langouet

    COO

  • Timothy Corbett-Clark

    CTO

  • Anne Grove

    Global Head HR & Development

  • Laura Budryte

    General Counsel

Our Guiding Principles that guide our decision making

At Cmed, oncology is what we do – 100% of our overall team has oncology experience with most team members averaging 15 years of industry experience. As an oncology CRO, we have performed more than 150 studies to date.

Learn more

Our Guiding Principles that guide our decision making

At Cmed, oncology is what we do – 100% of our overall team has oncology experience with most team members averaging 15 years of industry experience. As an oncology CRO, we have performed more than 150 studies to date.

Learn more

How quickly Cmed collectively got the study up and running with our first SIV and FPI likely to be ahead of the planned date. It has ‘mes merized the investors’.

…I wanted to extend my thanks from a DM perspective to the entire team for the effort and work you have put in throughout the year, to deliver something that is hugely complex and should have a big impact in the future. Although we have been impacted by COVID, you have all managed to keep some positivity and continue to drive forward at each timepoint and for this I am extremely thankful.”

How quickly Cmed collectively got the study up and running with our first SIV and FPI likely to be ahead of the planned date. It has ‘mesmerized the investors’.

Thanks to all of you for your hard work and efforts. The project is going very well and overall, the Sponsor is very happy.

Whats the latest at Cmed?

In the press